{
  "docId": "019de073-3800-772b-871e-98f0ed79adc7",
  "docSlug": "3d30d84bb133b7b226440021781a4f91",
  "documentTitle": "23andMe | Investor Presentation Deck | 58 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 40,
  "pageCount": 58,
  "prevPage": 39,
  "nextPage": 41,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a biological pathway diagram to illustrate the mechanism of action.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de073-3800-772b-871e-98f0ed79adc7/40",
  "deckHref": "/decks/019de073-3800-772b-871e-98f0ed79adc7",
  "deckJsonHref": "/decks/019de073-3800-772b-871e-98f0ed79adc7.json",
  "deckAnchorHref": "/decks/019de073-3800-772b-871e-98f0ed79adc7#slide-40",
  "components": [
    {
      "bbox": {
        "h": 0.556,
        "w": 0.556,
        "x": 0.414,
        "y": 0.288
      },
      "kind": "image",
      "text": "CD200:CD200R1 Signaling pathway diagram showing interaction between tumor cell and immune cell leading to reduced antitumor immune response.",
      "attrs": null,
      "subkind": "infographic",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5da9e151-1561-48c2-b15e-e410f5666142",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.588,
        "w": 0.352,
        "x": 0.036,
        "y": 0.264
      },
      "kind": "list",
      "text": "CD200R1 is an inhibitory receptor expressed on T-cells and myeloid cells. CD200 is the only known ligand for CD200R1 in humans and is highly expressed in certain cancers. Binding of CD200 to C200R1 decreases the ability of T-cells to recognize and kill cancer cells. Several viruses have co-opted CD200 analogues to suppress and evade the host immune response.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b4f7960-c076-44bb-bc28-1b4c120f05b0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.371,
        "x": 0.014,
        "y": 0.933
      },
      "kind": "source-note",
      "text": "References: J Virol 2012;86:6246, J Virol 2004;78:7667, J Immunol 2005;175:4441, Structure 2013;21:820, JCI Insight 2018;3:e96836",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e5785e1-237a-4208-856c-0fc4876dcbdf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.056,
        "w": 0.528,
        "x": 0.236,
        "y": 0.048
      },
      "kind": "title",
      "text": "CD200R1 is an Immune Checkpoint",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f86b124-7515-4b8b-ba2d-3f0917de0841",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}